Clinical Trial Update: Phase 2a Study of HPG1860 in Subjects With NASH [Phase 2]

View source ↗

Summary

Phase 2a study update for HPG1860 in NASH (nonalcoholic steatohepatitis) is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• HPG1860

Snippet

Sponsor: Hepagene (Shanghai) Co., Ltd. | Conditions: NASH - Nonalcoholic Steatohepatitis | Phase 2 | Status: UNKNOWN